Neha Krishnamohan brings extensive experience across strategic growth, business development, M&A and financing Jennifer Bush, Esq., who brings 14 years...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of...
Namilumab is a fully human monoclonal antibody that inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF), a pro-inflammatory cytokine believed to play a...
NEW YORK--(BUSINESS WIRE)--#biotech--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in...
Panel to discuss impact of popular weight-loss drugs on the self-funded employer marketNatchitoches, Louisiana--(Newsfile Corp. - April 25, 2024) -...
Vancouver, British Columbia--(Newsfile Corp. - April 25, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
Concentrated Formula Packed With Premium Ingredients for Optimal WellnessHAUPPAUGE, NY / ACCESSWIRE / April 25, 2024 / Nature's Answer, a...
Award Seeks to Demonstrate Feasibility of Manufacturing mRNA Vaccines in Only 7 Days STONY BROOK, NY / ACCESSWIRE / April...
JEFFERSONVILLE, IN / ACCESSWIRE / April 25, 2024 / PharmaCord LLC, a leading provider of patient support services for the...
TORONTO, ON / ACCESSWIRE / April 25, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way...
CAMBRIDGE, MA / ACCESSWIRE / April 25, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data...
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement, employers and other organizations tools to enhance public...
Toronto, Ontario--(Newsfile Corp. - April 25, 2024) - Celly Nutrition Corp. ("Celly Nu") is thrilled to unveil its groundbreaking partnership...
All 19,000 children in Compton schools will be provided with a vision screening along with eye exams, glasses and medical...
STOCKHOLM, SWEDEN / ACCESSWIRE / April 25, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced...
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024....
TAMPA, Fla., April 24, 2024 /PRNewswire/ -- St. Joseph's Hospital today announced that it becomes the first health care facility...